BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 18301024)

  • 21. Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration.
    Spaide RF
    Am J Ophthalmol; 2009 Apr; 147(4):644-52. PubMed ID: 19152869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pigment epithelial detachments with retinal vascular anomalous complex in age-related macular degeneration.
    Schneider U; Gelisken F; Inhoffen W; Bartz-Schmidt KU
    Ophthalmologica; 2005; 219(5):303-8. PubMed ID: 16123558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravitreal triamcinolone and laser photocoagulation for retinal angiomatous proliferation.
    Krieglstein TR; Kampik A; Ulbig M
    Br J Ophthalmol; 2006 Nov; 90(11):1357-60. PubMed ID: 16885191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for geographic atrophy after intravitreal ranibizumab injections for retinal angiomatous proliferation.
    Cho HJ; Yoo SG; Kim HS; Kim JH; Kim CG; Lee TG; Kim JW
    Am J Ophthalmol; 2015 Feb; 159(2):285-92.e1. PubMed ID: 25447115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re: Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration patients treated with ranibizumab.
    Uparkar M; Bhende M
    Retina; 2009; 29(10):1549; author reply 1549-50. PubMed ID: 19898197
    [No Abstract]   [Full Text] [Related]  

  • 26. Retinal angiomatous proliferation: association with clinical and angiographic features.
    Donati MC; Carifi G; Virgili G; Menchini U
    Ophthalmologica; 2006; 220(1):31-6. PubMed ID: 16374046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 1-year retrospective review of ranibizumab for naive nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Arias L; Ruiz-Moreno JM; Gómez-Ulla F; Fernández M; Montero J
    Retina; 2009; 29(10):1444-9. PubMed ID: 19730163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase-Resolved Doppler Optical Coherence Tomographic Features in Retinal Angiomatous Proliferation.
    Amarakoon S; de Jong JH; Braaf B; Yzer S; Missotten T; van Velthoven ME; de Boer JF
    Am J Ophthalmol; 2015 Nov; 160(5):1044-1054.e1. PubMed ID: 26210860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic evaluation of type 2 (classic) choroidal neovascularization: optical coherence tomography, indocyanine green angiography, and fluorescein angiography.
    Sulzbacher F; Kiss C; Munk M; Deak G; Sacu S; Schmidt-Erfurth U
    Am J Ophthalmol; 2011 Nov; 152(5):799-806.e1. PubMed ID: 21742302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Geographic atrophy in retinal angiomatous proliferation.
    McBain VA; Kumari R; Townend J; Lois N
    Retina; 2011 Jun; 31(6):1043-52. PubMed ID: 21317834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Retinal angiomatous proliferation in age-related macular degeneration].
    Kuerzinger GR; Lang GK; Lang GE
    Klin Monbl Augenheilkd; 2006 Aug; 223(8):691-5. PubMed ID: 16927227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF NEOVASCULAR MACULAR TELANGIECTASIA TYPE 2.
    Zhang Q; Wang RK; Chen CL; Legarreta AD; Durbin MK; An L; Sharma U; Stetson PF; Legarreta JE; Roisman L; Gregori G; Rosenfeld PJ
    Retina; 2015 Nov; 35(11):2285-99. PubMed ID: 26457402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical ablation of retinal angiomatous proliferation.
    Borrillo JL; Sivalingam A; Martidis A; Federman JL
    Arch Ophthalmol; 2003 Apr; 121(4):558-61. PubMed ID: 12695253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subfoveal choroidal thickness in retinal angiomatous proliferation.
    Yamazaki T; Koizumi H; Yamagishi T; Kinoshita S
    Retina; 2014 Jul; 34(7):1316-22. PubMed ID: 24406386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent retinal angiomatous proliferation after surgical ablation.
    Sakimoto S; Gomi F; Sakaguchi H; Tano Y
    Am J Ophthalmol; 2005 May; 139(5):917-8. PubMed ID: 15860303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration.
    Fung AT; Yannuzzi LA; Freund KB
    Retina; 2012 Oct; 32(9):1829-37. PubMed ID: 22850219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Histological characterization and classification of surgically excised choroid neovascular membranes].
    Spraul CW; Lang GE; Yoon HS; Grossniklaus HE; Lang GK
    Klin Monbl Augenheilkd; 1997 Nov; 211(5):324-34. PubMed ID: 9527590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time course of morphologic effects on different retinal compartments after ranibizumab therapy in age-related macular degeneration.
    Ahlers C; Golbaz I; Stock G; Fous A; Kolar S; Pruente C; Schmidt-Erfurth U
    Ophthalmology; 2008 Aug; 115(8):e39-46. PubMed ID: 18675694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraretinal crystalline deposits in neovascular age-related macular degeneration.
    Lima LH; Freund KB; Klancnik JM; Spaide RF
    Retina; 2010 Apr; 30(4):542-7. PubMed ID: 20084051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The first experience of intravitreal injection of Lucentis (ranibizumab) in the moist form of age-related maculodystrophy].
    Baĭborodov IaV
    Vestn Oftalmol; 2009; 125(5):31-3. PubMed ID: 19916331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.